GlobalDeal

Denali Therapeutics

Biotechnology · South San Francisco, United States

denalitherapeutics.com

About Denali Therapeutics

Denali Therapeutics is a biotechnology company focused on developing therapies for neurodegenerative diseases. Founded in 2013, the company is dedicated to addressing the unmet medical needs of patients suffering from conditions such as Alzheimer's disease, Parkinson's disease, and other related disorders. Denali employs a unique approach to drug development, leveraging its proprietary technologies to enhance the delivery of therapeutics across the blood-brain barrier, which is a significant challenge in treating neurological conditions. The company's pipeline includes several promising candidates that are in various stages of clinical development, aiming to provide innovative solutions that can improve the quality of life for patients. Denali's commitment to scientific excellence and collaboration with leading research institutions positions it as a key player in the biotechnology sector, particularly in the field of neurodegeneration.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Neurodegenerative Diseases, Drug Development, Clinical Research, Biopharmaceuticals
Location
South San Francisco, United States
Employees
1–10
Revenue (USD)
<1M

Products and services

Open Denali Therapeutics in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →